Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 17, 2024, titled "Press Release - Signing of Binding Letter of Intent for Preclinical Oncology Asset".
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 17, 2024, titled "Press Release - Signing of Binding Letter of Intent for Preclinical Oncology Asset".